On February 18, 2026, independent director Mr. Wenbin Wang resigned from Zhengye Biotechnology Holding Ltd.'s board and committees for personal reasons, leading to non-compliance with Nasdaq's independent director rule. The company plans to address this at its annual general meeting in March 2026.